Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2761–2784 of 145,445 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorder Clear all

Conditions: Eating Disorders
Interventions: Food Exposure Therapy and Ritual Prevention with Motivational Enhancement for Relapse Prevention in Anorexia Nervosa (AN-EX/RP), Cognitive behavioral therapy (CBT); Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 16 Years to 45 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Gastroparesis
Interventions: Nutrient drink; Dietary Supplement
Lead sponsor: Johns Hopkins University; Other
Eligibility: 16 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Clostridia Difficile Colitis, Clostridium; Sepsis
Interventions: Bezlotoxumab, Normal Saline; Biological · Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Respiratory Disease
Interventions: respiratory pathogen panel; Other
Lead sponsor: Data Collection Analysis Business Management; Other
Eligibility: 18 Years to 64 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Land O' Lakes, Florida

Conditions: Colorectal Cancer
Interventions: Tivozanib, Bevacizumab, mFOLFOX6; Drug
Lead sponsor: AVEO Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 27
States / cities: Gilbert, Arizona • Hot Springs, Arizona • Tucson, Arizona + 22 more

Conditions: Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma, Bithalamic High Grade Glioma, Brainstem Glioma, Glioblastoma, Anaplastic Astrocytoma
Interventions: ribociclib, Everolimus; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 12 Months to 30 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 7
States / cities: Washington D.C., District of Columbia • Chicago, Illinois • Charlotte, North Carolina + 4 more

Conditions: Atopic Dermatitis
Interventions: SAR444656 (KT-474), Placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 7
States / cities: Boynton Beach, Florida • Doral, Florida • Hollywood, Florida + 4 more

Conditions: Lymphoma
Interventions: CT-011, Rituximab; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Injury of Kidney, Acute Renal Failure
Interventions: I5NP (a small interfering RNA), placebo; Drug
Lead sponsor: Quark Pharmaceuticals; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 6
States / cities: Washington D.C., District of Columbia • Boston, Massachusetts • Cleveland, Ohio + 3 more

Conditions: Appendicitis, Appendicitis; Perforation
Interventions: Lactobacillus rhamnosus GG (LGG) Probiotic, Placebo; Dietary Supplement
Lead sponsor: Children's Health; Other
Eligibility: 4 Years to 18 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Respiratory Distress Syndrome, Adult
Interventions: Minimal (Trophic) Feeding, Full Feeding, Omega-3 Fatty Acids and Antioxidant Supplements, Placebo; Behavioral · Dietary Supplement
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 13 Years and older
Enrollment: 272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 41
States / cities: Fresno, California • Sacramento, California • San Francisco, California + 20 more

Conditions: Oropharyngeal Dysphagia
Interventions: Negative Pressure Suction Catheter; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Down Syndrome, Chromosome Disorders, Intellectual and Developmental Disabilities
Interventions: Not listed
Lead sponsor: RTI International; Other
Eligibility: Not listed
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 15
States / cities: Orange, California • Aurora, Colorado • Miami, Florida + 12 more

Conditions: Contraceptive, Sexually Transmitted Diseases
Interventions: Test Product, Control Product; Device
Lead sponsor: Church & Dwight Company, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Berkeley, California • Los Angeles, California

Conditions: Emergency
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Anxiety State
Interventions: Active CES, Sham CES; Device
Lead sponsor: Tufts University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Medford, Massachusetts

Conditions: Early Onset Alzheimer Disease, Mild Cognitive Impairment, Depression, Aging
Interventions: Not listed
Lead sponsor: ElMindA Ltd; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: The Villages, Florida

Conditions: Heart Failure, Obesity, Type 2 Diabetes Mellitus, Health Normal Volunteer Subjects
Interventions: [18F]FluorbetaOx; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Glucose Intolerance, Diabetes Mellitus, Type 2
Interventions: exercise and diet; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 40 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 1999
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Mild Cognitive Impairment
Interventions: Multi-domain Intervention; Other
Lead sponsor: Neurocore; Other
Eligibility: 55 Years to 85 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: Boca Raton, Florida • Palm Beach Gardens, Florida • Grandville, Michigan

Conditions: Cancer, Cancer Cachexia, Chronic Obstructive Pulmonary Disease, Chronic Heart Failure, Rheumatoid Arthritis
Interventions: Fish oil supplement; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 90 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Anaphylaxis, Hypotension, Bronchospasm, Angioedema
Interventions: Epinephrine, Omalizumab (Xolair), Placebos; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Opioid-use Disorder
Interventions: Case management; Behavioral
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 99 Years
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Stroke, Pain, Impaired Motor Function
Interventions: Miraπ, Mirror Therapy; Device · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Milford, Connecticut

Search by objective public record fields.

A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa

Nutritional Drink in Gastroparesis

Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.

How Respiratory Pathogens Panel Results Affect Patients' Plan of Care

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy

A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)

Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma

A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery

Probiotics and Antibiotic Associated Diarrhea in Pediatric Complicated Appendicitis

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

Utilization of Negative Pressure Suction to Reduce Aspiration in Oropharyngeal Dysphagia

Collaboration for Down Syndrome Progress (CDP)

Synthetic Male Condom Slippage-Breakage Study

Who Contributes to the Ordering of CT Scans in Emergency Department Patients?

Cranial Electrotherapy Stimulation and Acute Stress

Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain

Fatty Acid Radiotracer Comparison Study in Heart Failure Patients

Lifestyle Interventions to Reduce Diabetes Risk

Effects of Memory Boot Camp on Brain Function in Adults With Symptoms of Mild Cognitive Impairment (MCI)

A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss

A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder

Comparing Mirror Therapy Rehabilitation Device to Conventional Mirror Therapy